Volumetric changes and clinical trajectories in Parkinson's disease: a prospective multicentric study

被引:2
|
作者
Marques, Ana [1 ,2 ,3 ,53 ]
Macias, Elise [1 ,2 ,3 ]
Pereira, Bruno [4 ]
Durand, Elodie [1 ,2 ,3 ]
Chassain, Carine [1 ,2 ,3 ]
Vidal, Tiphaine [1 ,2 ,3 ]
Defebvre, Luc [5 ,6 ]
Carriere, Nicolas [5 ,6 ]
Fraix, Valerie [7 ,8 ]
Moro, Elena [7 ,8 ]
Thobois, Stephane [8 ,9 ,10 ,11 ]
Metereau, Elise [8 ,9 ,10 ,11 ]
Mangone, Graziella [12 ,13 ,14 ,15 ]
Vidailhet, Marie [12 ,13 ,14 ,15 ]
Corvol, Jean-Christophe [12 ,13 ,14 ,15 ]
Lehericy, Stephane [13 ,49 ,50 ,51 ,52 ]
de Champfleur, Nicolas Menjot [16 ,17 ]
Geny, Christian [18 ,19 ]
Spampinato, Umberto [20 ,21 ,22 ]
Meissner, Wassilios G. [20 ,21 ,23 ,24 ,54 ]
Frismand, Solene [25 ,26 ]
Schmitt, Emmanuelle [27 ]
de Maindreville, Anne Doe [28 ,29 ]
Portefaix, Christophe [30 ,31 ]
Remy, Philippe [32 ,33 ,34 ,35 ,36 ]
Fenelon, Gilles [32 ,33 ,34 ,35 ,36 ]
Houeto, Jean Luc [37 ,38 ,39 ,55 ]
Colin, Olivier [37 ,40 ,41 ]
Rascol, Olivier [42 ,43 ,44 ,45 ]
Peran, Patrice [46 ]
Bonny, Jean-Marie [47 ,48 ]
Fantini, Maria Livia [1 ,2 ,3 ]
Durif, Franck [1 ,2 ,3 ]
机构
[1] Univ Clermont Auvergne, Inst Pascal, CNRS, Clermont Auvergne INP,IGCNC, Clermont Ferrand, France
[2] Clermont Ferrand Univ Hosp, Neurol Dept, Clermont Ferrand, France
[3] Clermont Ferrand Univ Hosp, NS PARK FCRIN Network, Clermont Ferrand, France
[4] Clermont Ferrand Univ Hosp, Biostat Unit DRCI, Clermont Ferrand, France
[5] Univ Lille, Dept Movement Disorder, Inserm 1172, Lille, France
[6] Univ Lille, NS PARK FCRIN Network, Inserm 1172, Lille, France
[7] Univ Grenoble Alpes, Grenoble Inst Neurosci, Serv Neurol, CHU Grenoble, Grenoble, France
[8] NS PARK FCRIN Network, Grenoble, France
[9] CNRS, Inst Sci Cognit Marc Jeannerod, UMR 5229, CNRS, Lyon, France
[10] Univ Claude Bernard Lyon 1, Lyon, France
[11] Hop Neurol & Neurochirurg P Wertheimer, Hosp Civils Lyon, Serv Neurol C, Lyon, France
[12] Sorbonne Univ, Dept Neurol, Paris, France
[13] Sorbonne Univ, NS PARK FCRIN Network, Paris, France
[14] AP HP, Inst Cerveau ICM, Paris, France
[15] Hop La Pitie Salpetriere, CNRS 7225, CIC Neurosci, Inserm 1127, Paris, France
[16] Montpellier Univ Hosp Ctr, Gui de Chauliac Hosp, Dept Neuroradiol, Montpellier, France
[17] CHRU Montpellier, Inst Imagerie Fonct Humaine, I2FH, Hop Gui de Chauliac, Montpellier, France
[18] Montpellier Univ, Montpellier Univ Hosp, Dept Geriatr, Montpellier, France
[19] Montpellier Univ, Montpellier Univ Hosp, NS PARK FCRIN Network, Montpellier, France
[20] CHU Bordeaux, Serv Neurol Malad Neurodegenerat, F-33000 Bordeaux, France
[21] CHU Bordeaux, NS PARK FCRIN Network, F-33000 Bordeaux, France
[22] Univ Bordeaux, Team P3TN, INCIA UMR 5287, CNRS, Bordeaux, France
[23] Univ Bordeaux, CNRS, IMN, UMR 5293, F-33000 Bordeaux, Bordeaux, France
[24] Univ Otago, Dept Med, Christchurch, New Zealand
[25] Nancy Univ Hosp Ctr, Dept Neurol, Nancy, France
[26] Nancy Univ Hosp Ctr, NS PARK FCRIN Network, Nancy, France
[27] Nancy Univ Hosp Ctr, Dept Neuroradiol, Nancy, France
[28] Hop Maison Blanche, Dept Neurol, Reims, France
[29] Hop Maison Blanche, NS PARK FCRIN Network, Reims, France
[30] Hop Maison Blanche, Dept Radiol, Reims, France
[31] Univ Reims, CReSTIC Lab, Reims, France
[32] CHU Henri Mondor, Ctr Expert Parkinson, Creteil, France
[33] CHU Henri Mondor, NS PARK FCRIN Network, Creteil, France
[34] Univ Paris Est Creteil, AP HP, Creteil, France
[35] Univ Paris Est Creteil, Fac Sante, Equipe Neuropsychol Intervent, INSERM IMRB, Creteil, France
[36] Paris Sorbonne Univ, Ecole Normale Super, Creteil, France
[37] Univ Poitiers, Ctr Invest Clin CIC1402, INSERM, CHU Poitiers, Poitiers, France
[38] Serv Neurol, Poitiers, France
[39] NS PARK FCRIN Network, Poitiers, France
[40] CH Brive la Gaillarde, Serv Neurol, Poitiers, France
[41] CH Brive la Gaillarde, NS PARK FCRIN Network, Poitiers, France
[42] CHU Toulouse, Ctr Expert Parkinson, Dept Pharmacol Clin, INSERM,Ctr Invest Clin CIC 1436,UMR 1214 TONIC,Ne, Toulouse, France
[43] CHU Toulouse, Dept Neurosci, Ctr Expert Parkinson, INSERM,Ctr Invest Clin CIC 1436,UMR 1214 TONIC,Ne, Toulouse, France
[44] CHU Toulouse, NS PARK FCRIN Network, INSERM, Toulouse, France
[45] Univ Toulouse 3, Toulouse, France
[46] Univ Toulouse, Toulouse NeuroImaging Ctr, ToNIC, INSERM,UPS, Toulouse, France
[47] INRAE, UR QuaPA, F-63122 St Genes Champanelle, France
[48] INRAE, AgroResonance, Nucl Magnet Resonance Facil Agron Food & Hlth, F-2018 St Genes Champanelle, France
[49] Sorbonne Univ, Dept Neuroradiol, Paris, France
[50] AP HP, Inst Cerveau ICM, Paris, France
关键词
Parkinson's disease; Volumetric changes; Brain atrophy; Clinical progression; Longitudinal study; RATING-SCALE; MATTER CHANGES; ATROPHY; PROGRESSION; VALIDATION; GAIT;
D O I
10.1007/s00415-023-11947-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundLongitudinal measures of structural brain changes using MRI in relation to clinical features and progression patterns in PD have been assessed in previous studies, but few were conducted in well-defined and large cohorts, including prospective clinical assessments of both motor and non-motor symptoms.ObjectiveWe aimed to identify brain volumetric changes characterizing PD patients, and determine whether regional brain volumetric characteristics at baseline can predict motor, psycho-behavioral and cognitive evolution at one year in a prospective cohort of PD patients.MethodsIn this multicentric 1 year longitudinal study, PD patients and healthy controls from the MPI-R2* cohort were assessed for demographical, clinical and brain volumetric characteristics. Distinct subgroups of PD patients according to motor, cognitive and psycho-behavioral evolution were identified at the end of follow-up.ResultsOne hundred and fifty PD patients and 73 control subjects were included in our analysis. Over one year, there was no significant difference in volume variations between PD and control subjects, regardless of the brain region considered. However, we observed a reduction in posterior cingulate cortex volume at baseline in PD patients with motor deterioration at one year (p = 0.017). We also observed a bilateral reduction of the volume of the amygdala (p = 0.015 and p = 0.041) and hippocampus (p = 0.015 and p = 0.053) at baseline in patients with psycho-behavioral deterioration, regardless of age, dopaminergic treatment and center.ConclusionBrain volumetric characteristics at baseline may predict clinical trajectories at 1 year in PD as posterior cingulate cortex atrophy was associated with motor decline, while amygdala and hippocampus atrophy were associated with psycho-behavioral decline.
引用
收藏
页码:6033 / 6043
页数:11
相关论文
共 50 条
  • [31] Step length predicts executive dysfunction in Parkinson's disease: a 3-year prospective study
    Amboni, Marianna
    Iuppariello, Luigi
    Iavarone, Alessandro
    Fasano, Alfonso
    Palladino, Raffaele
    Rucco, Rosaria
    Picillo, Marina
    Lista, Ilaria
    Varriale, Pasquale
    Vitale, Carmine
    Cesarelli, Mario
    Sorrentino, Giuseppe
    Barone, Paolo
    JOURNAL OF NEUROLOGY, 2018, 265 (10) : 2211 - 2220
  • [32] Health related quality of life in Parkinson's disease:: a prospective longitudinal study
    Karlsen, KH
    Tandberg, E
    Årsland, D
    Larsen, JP
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 69 (05) : 584 - 589
  • [33] Longitudinal Prediction of Freezing of Gait in Parkinson's Disease: A Prospective Cohort Study
    Zhao, Jiahao
    Wan, Ying
    Song, Lu
    Wu, Na
    Zhang, Zien
    Liu, Zhenguo
    Gan, Jing
    FRONTIERS IN NEUROLOGY, 2022, 12
  • [34] Hyperhidrosis in Parkinson's disease: a 3-year prospective cohort study
    Lin, J.
    Ou, R.
    Wei, Q.
    Cao, B.
    Li, C.
    Hou, Y.
    Zhang, L.
    Liu, K.
    Shang, H.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2022, 36 (07) : 1104 - 1112
  • [35] Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study
    Fereshtehnejad, Seyed-Mohammad
    Yao, Chun
    Pelletier, Amelie
    Montplaisir, Jacques Y.
    Gagnon, Jean-Francois
    Postuma, Ronald B.
    BRAIN, 2019, 142 : 2051 - 2067
  • [36] Trajectories of prediagnostic functioning in Parkinson's disease
    Darweesh, Sirwan K. L.
    Verlinden, Vincentius J. A.
    Stricker, Bruno H.
    Hofman, Albert
    Koudstaal, Peter J.
    Ikram, M. Arfan
    BRAIN, 2017, 140 (02) : 429 - 441
  • [37] Trajectories of prediagnostic functioning in Parkinson's disease
    Darweesh, Sirwan K. L.
    Verlinden, Vincentius J. A.
    Stricker, Bruno H.
    Hofman, Albert
    Koudstaal, Peter J.
    Ikram, M. Arfan
    BRAIN, 2017, 140 : 429 - 441
  • [38] Clinical and cerebral activity changes induced by subthalamic nucleus stimulation in advanced Parkinson's disease: A prospective case-control study
    Cilia, Roberto
    Marotta, Giorgio
    Landi, Andrea
    Isaias, Ioannis U.
    Mariani, Claudio B.
    Vergani, Francesco
    Benti, Riccardo
    Sganzerla, Erik
    Pezzoli, Gianni
    Antonini, Angelo
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2009, 111 (02) : 140 - 146
  • [39] Rate of cognitive decline in premotor Parkinson's disease: A prospective study (NEDICES)
    Sanchez-Ferro, Alvaro
    Benito-Leon, Julian
    Louis, Elan D.
    Mitchell, Alex J.
    Antonio Molina-Arjona, Jose
    Trincado, Rocio
    Villarejo, Alberto
    Bermejo-Pareja, Felix
    MOVEMENT DISORDERS, 2013, 28 (02) : 161 - 168
  • [40] Gray Matter Changes in Parkinson's and Alzheimer's Disease and Relation to Cognition
    Krajcovicova, Lenka
    Klobusiakova, Patricia
    Rektorova, Irena
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2019, 19 (11)